| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |